The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca Japan; BD Biosciences; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Illumina; Lilly Japan; MSD K.K; Ono Pharmaceutical
Consulting or Advisory Role - Kyowa Hakko Kirin; Novartis; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Lilly (Inst); Ono Pharmaceutical (Inst)
Immunological impact of ramucirumab on tumor microenvironment in advanced gastric cancer.
 
Yosuke Togashi
No Relationships to Disclose
 
Yasuko Tada
No Relationships to Disclose
 
Daisuke Kotani
No Relationships to Disclose
 
Akihito Kawazoe
Research Funding - Taiho Pharmaceutical (Inst)
 
Toshihiko Doi
Consulting or Advisory Role - Amgen; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; MSD
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Hiroyoshi Nishikawa
Honoraria - Bristol-Myers Squibb Japan; Ono Pharmaceutical
Research Funding - Bristol-Myers Squibb Japan (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Ono Pharmaceutical (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Zenyaku Kogyo (Inst)
 
Kohei Shitara
Honoraria - Abbvie; Novartis; Yakult Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Lilly; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)